October 16, 2009 – Correlagen recently expanded its CardioGeneScan test, the first comprehensive genetic test for the diagnosis of familial cardiac disease.

October 16, 2009 – AstraZeneca yesterday said the U.S. Food and Drug Administration cleared CRESTOR (rosuvastatin calcium) for use in pediatric patients ages 10-17 with heterozygous familial hypercholesterolemia (HeFH) when diet therapy fails to reduce elevated cholesterol.

October 16, 2009 – BIOTRONIK yesterday said it recently received the Industry’s first European CE Mark approval so BIOTRONIK Home Monitoring can replace in-hospital device follow-up visits.

October 16, 2009 – The Clinical Center of Serbia, Institute for Cardiovascular Diseases today said it treated its first patient with a revolutionary cell-based therapy for heart failure.

October 16, 2009 - At the 95th annual RSNA meeting, Nov. 29-Dec 4, in Chicago, Agfa Healthcare will show how IMPAX Cardiovascular is designed to support heart and vascular diagnostics and documentation.

October 15, 2009 – Kardia Health Systems, today announced the availability of ConnectedCare, the first complete, online, fee-per-study cardiovascular information system (CVIS).

October 15, 2009 – A study conducted by the University of Rochester Medical Center (URMC) demonstrates that, for certain patient populations, an experimental device that lowers blood pressure may be a cost effective treatment. The implantable device, called Rheos, is in advanced stages of testing for individuals with drug-resistant hypertension.

October 15, 2009 – Biosense Webster Inc. said today the U.S. Food and Drug Administration cleared the CARTO 3 System, an advanced 3D imaging technology for use by electrophysiologists in treating cardiac arrhythmias.

Datascope’s CS100 Intra-Aortic Balloon Pump with IntelliSync offers one-button start up and it automatically adapts to changing conditions.

The device automatically evaluates and selects optimal trigger source and lead, sets inflation at the dicrotic notch and deflates the balloon at the start of systole. It responds to changes in signal quality by selecting a new trigger source.

October 14, 2009 — During the Chicago Heart Failure Forum, Abraham Kocheril, M.D., professor of Medicine and director of clinical electrophysiology at the University of Illinois at Chicago, together with Thomas Stamos, M.D., director of heart failure at the University of Illinois Medical Center, presented a heart failure patient case study in which the Shape-HF Cardiopulmonary Exercise Testing S

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now